Explore 3 Stock Ideas & Industry Insights Download Free Report

General News

Why Did Positive Melanoma Data Fail to Stop Moderna (NASDAQ:MRNA) From Sliding 4%?

Moderna (NASDAQ:MRNA) remained under pressure because an apparently early release of Phase 3 melanoma findings delivered a smaller benefit than the market's most optimistic assumptions. The stock traded at USD 193.62 during the morning of Friday, October 23, 2026, down roughly 4% after Thursday's …

Vinay Lochav | 26 October 2026

Could a New 1.6T Cable Rival Explain Credo's (NASDAQ:CRDO) 9.5% Retreat?

A potential challenge to its leadership in short-distance AI connections drove Credo (NASDAQ:CRDO) to a six-month low. Shares ended Friday, October 23, 2026 down 9.51% after MaxLinear used its third-quarter 2026 earnings discussion to declare an intended share between one-fifth and three-tenths of 1.6T …

Vinay Lochav | 26 October 2026

Does CoreWeave's (NASDAQ:CRWV) 1,129-Basis-Point Credit Alarm Matter More Than Its New Low?

Both valuation cuts and expensive default protection pushed CoreWeave (NASDAQ:CRWV) to a fresh 52-week low. The GPU-cluster rental company closed Friday, October 23, 2026 down 2.46% after trading near USD 53.50.

Vinay Lochav | 26 October 2026

Why Did an 82% Response Rate Fail to Support Tango Therapeutics (NASDAQ:TNGX)?

Tango Therapeutics (NASDAQ:TNGX) sold off because strong pancreatic cancer findings did not clear an even higher bar set by an earlier update and a steep rally. The stock dropped from Thursday's USD 27.93 close to USD 23.40 in early Friday trading on October 23, …

Vinay Lochav | 26 October 2026

Can Volatility Keep Lifting Cboe (CBOE:CBOE) After Its 3.88% Gain?

Cboe (CBOE:CBOE) outperformed a falling market after receiving Morgan Stanley's preferred designation and a USD 450 objective. Shares added 3.88% on Friday, October 23, 2026. Compared with the earlier USD 358 figure, the change was roughly 25.7% based on simple arithmetic.

Vinay Lochav | 26 October 2026

What Is Supporting Allegion (NYSE:ALLE) After Its 1.39% Advance?

Allegion (NYSE:ALLE) advanced 1.39% in Friday's October 23, 2026 session because BofA lifted the security-products maker to Buy and increased its objective, which now stands at USD 200. The bank expects demand recovery and higher sales volumes to improve the valuation. That support appeared …

Vinay Lochav | 26 October 2026

What Is Netflix (NASDAQ:NFLX) Missing Despite Stronger Margins and Buybacks?

Netflix (NASDAQ:NFLX) was quoted around USD 66 during the Friday, October 23, 2026 session, leaving a year-to-date loss near 29%. Investors focused on management's USD 300 million reduction to 2026 advertising expectations, from USD 3 billion down to approximately USD 2.7 billion. The current …

Vinay Lochav | 26 October 2026

Can Nike (NYSE:NKE) Rebuild Credibility at Its November Investor Day?

Nike (NYSE:NKE) must present believable multi-year sales and margin objectives that distinguish cost reduction from genuine demand improvement. The athletic footwear and clothing company announced the event after Friday's close on October 23, 2026, at 4:15 p.m. ET. The two-day program covers November 16 …

Vinay Lochav | 26 October 2026

What Is Behind Newell Brands' (NASDAQ:NWL) 6.5% Broker-Led Decline?

Newell Brands (NASDAQ:NWL) lost 6.5% during the Friday session dated October 23, 2026. UBS reiterated Neutral but challenged whether the household-products company's profit recovery is sustainable. A week earlier, on October 16, 2026, the latest share price was USD 5.65 while the broker's objective …

Vinay Lochav | 26 October 2026

Why Could Rocket Lab's (NASDAQ:RKLB) 98th Electron Flight Matter Beyond One Launch?

Rocket Lab (NASDAQ:RKLB) said on Friday, October 23, 2026 that Electron's 98th flight had succeeded, carrying satellites for HawkEye 360. It was the customer's third mission dedicated entirely to Electron. The event supplies additional evidence of regular launches and returning buyers rather than announcing …

Vinay Lochav | 26 October 2026
Support

Hi! How can we help you today?

Loading…